
handle: 10576/62403
This chapter discusses the common types of medications associated with medication-related osteonecrosis of jaw (MRONJ) including bisphosphates, monoclonal antibodies and anti-angiogenic agents. Risk assessment of patients, pre-treatment prevention and management principles of MRONJ in general dental practice settings are outlined. The readers are signposted to useful online resources on the prevention and management of MRONJ along with resources which may be used for patient education. Scopus
prevention, anti-angiogenic agents, dentistry, antiresorptive medications, prevention, management, 610, monoclonal antibodies, bisphosphonates, management, oral surgery
prevention, anti-angiogenic agents, dentistry, antiresorptive medications, prevention, management, 610, monoclonal antibodies, bisphosphonates, management, oral surgery
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
